Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial
François Rannou(Délégation Paris 5), Serge Poiraudeau(Institut Régional de Médecine Physique et de Réadaptation), Luc Mouthon(Université Paris Cité), É. Hachulla(Centre Hospitalier Universitaire de Lille), Gabriel Baron(Délégation Paris 5), A. Bérezné(Université Paris Cité), Philippe Ravaud(Inserm), Isabelle Boutron(Inserm), Raphaël Porcher(Hotel Dieu Hospital), V. Tiffreau(Université de Lille), Emmanuel Chatelus(Laboratoire National de Référence), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Loı̈c Guillevin(Unknown), Katherine Sanchez(Délégation Paris 5), J. Cabané(Sorbonne Université), Philipe Thoumie(Sorbonne Université), Alexandra Rören(Délégation Paris 5)
Cited by 79
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|UNC Libraries|2020|1.3k
Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis
|Journal of the American Society of Nephrology|2007|1.1k